A novel protease homolog differentially expressed in breast and ovarian cancer
about
Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expressionHigher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistanceKallikreins are associated with secondary progressive multiple sclerosis and promote neurodegenerationThe androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancerQuantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosisImmunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarkerHuman kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancerExpression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal statusKallikrein gene downregulation in breast cancer.Substrate specificity of human kallikreins 1 and 6 determined by phage display.Functional role of kallikrein 6 in regulating immune cell survival.Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathyDifferential Gene Expression Landscape of Co-Existing Cervical Pre-Cancer Lesions Using RNA-seqKallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patientsLymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancerRe-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6.Characterisation of human kallikrein 6/protease M expression in ovarian cancer.Correlation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancerKLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.Identification of human tissue kallikrein 6 as a potential marker of laryngeal cancer based on the relevant secretory/releasing protein database.KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species.Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas.Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms
P2860
Q22009031-9577B881-B7E1-4458-98C3-A309ADDF087EQ24642804-8A40C1EE-F774-49D9-A61F-A5433CBA9D45Q24643613-9FB942B1-1EA9-4F88-B64F-E3B5F382C29BQ24646770-599E04BF-8490-45F0-8506-B49041FFD88DQ24646799-CDF6F9D4-63D4-41D8-BCF9-78ED7E04D23CQ24648238-BC00EAE0-FF3F-4AEA-A271-A35EAF82B542Q24648770-FF93FE08-7BB5-4FB6-97D8-EAF215B0C46BQ24652262-A763D96B-6427-43F5-8B27-225F968D03BDQ30438640-36CFBC8F-EBF4-4848-AB01-86A8B8AE2E77Q33325124-4855E19C-3EE1-4C48-BA74-94D50BB3A686Q33862447-190B4A22-BEFF-40B3-B73A-5FF28D8320A1Q34544824-91EC36B0-9D1B-42FD-B175-43B0838BA66BQ34574451-979B15D4-697B-415B-86A6-6E8FC3666199Q35623800-B74A87EB-847E-4EBE-997B-BA2FC00F4889Q36075255-E97D5999-DF86-4E00-B6E3-582388B49CD9Q36438497-BC45A3AD-DB91-4B97-BF58-45AA07F41B95Q36560848-D98E8522-C0DC-43CC-A642-4E42FDF1F412Q36626102-D0DBB917-A873-4E9F-9176-BE8B83288F4CQ36908718-55ACC941-384E-41D6-A0CD-C7839C4ABD39Q37400530-9A1A2102-8F7B-4E00-8CEB-60283C415C3BQ37616960-B8FA8B37-7234-422E-9F91-E97F368391D3Q37716380-302DF4DF-A22D-4F8E-AEC3-3F01B0F9F55EQ39187457-7716CFAD-BD76-4571-8388-54257BEE5BF3Q39839292-2CE151B0-5B23-48CC-B6B8-660290ACC47AQ39945610-659ACDE7-6273-42AE-8C88-F42187AAFE60Q41129839-70E06E48-6EAE-4A72-8DEC-C760A321464BQ41466936-D744E943-909C-494F-B774-A78E13C8F5EBQ58699560-1DA02EDF-2D2F-4108-922C-6D25C7774FBC
P2860
A novel protease homolog differentially expressed in breast and ovarian cancer
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A novel protease homolog differentially expressed in breast and ovarian cancer
@ast
A novel protease homolog differentially expressed in breast and ovarian cancer
@en
A novel protease homolog differentially expressed in breast and ovarian cancer
@nl
type
label
A novel protease homolog differentially expressed in breast and ovarian cancer
@ast
A novel protease homolog differentially expressed in breast and ovarian cancer
@en
A novel protease homolog differentially expressed in breast and ovarian cancer
@nl
prefLabel
A novel protease homolog differentially expressed in breast and ovarian cancer
@ast
A novel protease homolog differentially expressed in breast and ovarian cancer
@en
A novel protease homolog differentially expressed in breast and ovarian cancer
@nl
P2093
P2860
P356
P1433
P1476
A novel protease homolog differentially expressed in breast and ovarian cancer
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03401646
P407
P577
1996-09-01T00:00:00Z
P6179
1082991404